Comparative study of safety and efficacy profile of repaglinide and voglibose on targeting post prandial hyperglycemia in patients with newly diagnosed type II diabetes mellitus

Autor:	Jyoti A. Bobde, Deepak Bhosle, Rajesh Kadam
Rok vydání:	2018
Předmět:	Post-prandial Type ii diabetes medicine.medical_specialty business.industry Internal medicine Voglibose Medicine In patient Newly diagnosed business Repaglinide medicine.drug
Zdroj:	International Journal of Basic & Clinical Pharmacology. 7:2325
ISSN:	2279-0780 2319-2003
DOI:	10.18203/2319-2003.ijbcp20184840
Popis:	Background: In India the number of people with diabetes is increasing day-by-day. Due to a sole “Asian Indian Phenotype,” Indians develop diabetes an era earlier and have an earlier onset of complications. Therefore, it is essential to evaluate more effective treatment strategies at an earlier stage of disease progression.Methods: The present study was prospective, open label, comparative, randomized, parallel group, single center study. Comparison of two post prandial active treatment groups over a period of 3 months. Sixty patients of either sex in the age group of 30-60years with newly diagnosed type II diabetes mellitus, with prandial blood glucose levels >180mg% and
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a7ab7c0aa62666a61b38c7eb8f57eb3c https://doi.org/10.18203/2319-2003.ijbcp20184840 Zobrazit plný text záznamu